{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:25:36Z","timestamp":1786947936896,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Chronic immune activation and systemic inflammation persist in people with HIV (PWH) despite effective antiretroviral therapy, contributing to increased cardiovascular and cancer risk. Monocytes play a central role in this process, partly through type I interferon (IFN-I) signalling. As Toll-like receptor (TLR) 3 and 7 are key inducers of endogenous IFN-I in response to viral RNA, we investigated how TLR3 and TLR7 stimulation contributes to IFN-I\u2013driven monocyte activation, and whether this response \u2013 potentially involving both direct TLR signalling and IFN-I-mediated amplification \u2013 can be modulated by JAK-STAT inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>We assessed IFN-mediated monocyte activation following TLR3 and TLR7 stimulation and evaluated the effect of JAK-STAT inhibition on the expression of activation markers, immune checkpoint ligands, and cytokine production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Monocytes isolated by negative selection from peripheral blood mononuclear cells (PBMCs) of PWH were stimulated with the TLR3 agonist Poly(I:C), the TLR7 agonist Imiquimod, or IFN-\u03b12a. Cells were treated with the JAK1\/2 inhibitor Baricitinib or the TYK2-selective inhibitor Deucravacitinib. Activation markers, immune checkpoint proteins, and cytokines were analyzed at 4\u200ah and\/or 24\u200ah using flow cytometry, qPCR, and ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>TLR stimulation induced IFN-mediated activation in monocytes from PWH, with increased PD-L1, CD80 and HLA-DR expression, CXCL10 production, and a shift toward pro-inflammatory subsets. JAK-STAT inhibitors significantly reduced PD-L1 and CXCL10 levels and partially decreased TIM-3 expression, particularly at 24\u200ah.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>TLR3 and TLR7 agonists induce IFN-driven monocyte activation in PWH, which is effectively modulated by JAK-STAT inhibitors. These findings support their potential as therapeutic agents to mitigate inflammation in chronic HIV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/qad.0000000000004530","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:01:28Z","timestamp":1777978888000},"page":"1236-1242","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of Toll-like receptor driven monocyte activation by JAK-STAT inhibitors in people with HIV"],"prefix":"10.1097","volume":"40","author":[{"given":"Marion","family":"Camard","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"},{"name":"AP-HP, H\u00f4pital Bic\u00eatre, Service de M\u00e9decine Interne et Immunologie Clinique, Le Kremlin Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Pla\u00e7ais","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"},{"name":"AP-HP, H\u00f4pital Bic\u00eatre, Service de M\u00e9decine Interne et Immunologie Clinique, Le Kremlin Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bitu","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelliah","family":"Mouanga","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Bourdic","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Bic\u00eatre, Service de M\u00e9decine Interne et Immunologie Clinique, Le Kremlin Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick-Ryan","family":"Magagi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Paoletti","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"},{"name":"AP-HP, H\u00f4pital Bic\u00eatre, Service de M\u00e9decine Interne et Immunologie Clinique, Le Kremlin Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Noel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, CEA; Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184); Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre"},{"name":"AP-HP, H\u00f4pital Bic\u00eatre, Service de M\u00e9decine Interne et Immunologie Clinique, Le Kremlin Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","article-title":"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection","volume":"16","author":"Said","year":"2010","journal-title":"Nat Med"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"103129","DOI":"10.1016\/j.ebiom.2020.103129","article-title":"Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection","volume":"62","author":"Novelli","year":"2020","journal-title":"eBioMedicine"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood-2002-10-3065","article-title":"B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression","volume":"101","author":"Trabattoni","year":"2003","journal-title":"Blood"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"e0258122","DOI":"10.1371\/journal.pone.0258122","article-title":"PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV","volume":"16","author":"Tamene","year":"2021","journal-title":"PLoS One"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"20627","DOI":"10.1038\/s41598-025-04613-0","article-title":"Increased IFN responses drive myeloid cell activation in people living with HIV-1","volume":"15","author":"Pla\u00e7ais","year":"2025","journal-title":"Sci Rep"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/QAD.0b013e3282f4de23","article-title":"Up-regulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands","volume":"22","author":"Meier","year":"2008","journal-title":"AIDS"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"106454","DOI":"10.1016\/j.isci.2023.106454","article-title":"Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection","volume":"26","author":"Mackelprang","year":"2023","journal-title":"iScience"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"e1006740","DOI":"10.1371\/journal.ppat.1006740","article-title":"Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors","volume":"13","author":"Gavegnano","year":"2017","journal-title":"PLoS Pathog"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/cid\/ciab212","article-title":"Randomized trial of ruxolitinib in antiretroviral-treated adults with human immunodeficiency virus","volume":"74","author":"Marconi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/JVI.02214-20","article-title":"Effect of the use of galectin-9 and blockade of the TIM-3 receptor in the latent cellular reservoir of HIV-1","volume":"95","author":"Sanz","year":"2021","journal-title":"J Virol"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1038\/nmicrobiol.2016.246","article-title":"Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes","volume":"2","author":"Lachmandas","year":"2016","journal-title":"Nat Microbiol"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41467-021-22375-x","article-title":"Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells","volume":"12","author":"Rhodes","year":"2021","journal-title":"Nat Commun"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"720697","DOI":"10.3389\/fimmu.2021.720697","article-title":"The effect of JAK1\/2 inhibitors on HIV reservoir using primary lymphoid cell model of HIV latency","volume":"12","author":"de Armas","year":"2021","journal-title":"Front Immunol"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/QAD.0000000000001533","article-title":"Writing committee of the CD4+\/CD8+ Ratio Working Group of the French Hospital Database on HIV (FHDH-ANRS CO4). CD4+\/CD8+ ratio restoration in long-term treated HIV-1-infected individuals","volume":"31","author":"Caby","year":"2017","journal-title":"AIDS"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","article-title":"CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study","volume":"2","author":"Mussini","year":"2015","journal-title":"Lancet HIV"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"e55279","DOI":"10.1371\/journal.pone.0055279","article-title":"Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women","volume":"8","author":"Martin","year":"2013","journal-title":"PLoS One"},{"key":"R26-20260817","first-page":"80","article-title":"Monocytes are the main source of STING-mediated IFN-\u03b1 production","author":"Congy-Jolivet","year":"2022","journal-title":"eBioMedicine"},{"issue":"(Suppl 3)","key":"R27-20260817","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1093\/infdis\/jiu175","article-title":"Sex-based differences in HIV type 1 pathogenesis","volume":"209","author":"Addo","year":"2014","journal-title":"J Infect Dis"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1097\/QAD.0000000000000817","article-title":"Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy","volume":"29","author":"Conley","year":"2015","journal-title":"AIDS"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"eadl0368","DOI":"10.1126\/sciadv.adl0368","article-title":"JAK\/STAT signaling pathway affects CCR5 expression in human CD4+ T cells","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0000000000004530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:00:26Z","timestamp":1786946426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0000000000004530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0000000000004530","relation":{},"ISSN":["0269-9370","1473-5571"],"issn-type":[{"value":"0269-9370","type":"print"},{"value":"1473-5571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2025-06-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}